The new company will develop microbiome diagnostics for multiple indications including inflammatory bowel disease and liver disorders.
The companies will discover and develop microbiome-derived biomarkers, drug targets, and bioactive molecules for cancer.
The New York Times profiles 23andMe's Anne Wojcicki and describes how she bounced back from a bad year.
Fotis Kafatos, the founding president of the European Research Council, has died, according to the Associated Press.
In PLOS this week: genomic analysis of honeybee disease, microRNA profiles of people with lupus nephritis, and more.
The Verge's Angela Chen tried out a gene test for fitness advice, but didn't learn much new information.